Diptee Kulkarni

4.4k total citations
13 papers, 304 citations indexed

About

Diptee Kulkarni is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Diptee Kulkarni has authored 13 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Genetics. Recurrent topics in Diptee Kulkarni's work include Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (2 papers) and Melanoma and MAPK Pathways (2 papers). Diptee Kulkarni is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (2 papers) and Melanoma and MAPK Pathways (2 papers). Diptee Kulkarni collaborates with scholars based in United States, United Kingdom and Switzerland. Diptee Kulkarni's co-authors include Kim M. Hirshfield, Ahamed Saleem, Pooja Pungaliya, Eric H. Rubin, Alexei Vázquez, Deborah Toppmeyer, Arnold J. Levine, Hyejin Park, Haiyan Zheng and Henry Lackland and has published in prestigious journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Biochemistry.

In The Last Decade

Diptee Kulkarni

13 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diptee Kulkarni United States	10	192	103	41	41	38	13	304
Donna Hewitt Canada	5	194 1.0×	94 0.9×	25 0.6×	63 1.5×	43 1.1×	12	351
Colan Ho-Yen United Kingdom	7	122 0.6×	138 1.3×	33 0.8×	80 2.0×	20 0.5×	12	288
Jiandong Tong China	8	159 0.8×	116 1.1×	43 1.0×	58 1.4×	16 0.4×	10	297
Zhangwei Tong China	9	235 1.2×	90 0.9×	30 0.7×	106 2.6×	46 1.2×	17	347
Ying‐Chao Wang China	7	212 1.1×	130 1.3×	21 0.5×	66 1.6×	20 0.5×	8	349
Kanyalakshmi Ayyanar United States	7	214 1.1×	83 0.8×	14 0.3×	35 0.9×	23 0.6×	10	351
Jianjian Dai China	12	243 1.3×	98 1.0×	32 0.8×	84 2.0×	13 0.3×	19	409
Kyung Joo Cho South Korea	9	172 0.9×	77 0.7×	33 0.8×	60 1.5×	20 0.5×	15	317
Katy Billot France	11	172 0.9×	51 0.5×	23 0.6×	59 1.4×	60 1.6×	15	292

Countries citing papers authored by Diptee Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Diptee Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diptee Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diptee Kulkarni more than expected).

Fields of papers citing papers by Diptee Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diptee Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diptee Kulkarni. The network helps show where Diptee Kulkarni may publish in the future.

Co-authorship network of co-authors of Diptee Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Diptee Kulkarni. A scholar is included among the top collaborators of Diptee Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diptee Kulkarni. Diptee Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Carss, Keren, Aimée M. Deaton, Alberto Del Río-Espínola, et al.. (2022). Using human genetics to improve safety assessment of therapeutics. Nature Reviews Drug Discovery. 22(2). 145–162. 42 indexed citations

Yau, Thomas, Riccardo Lencioni, Wattana Sukeepaisarnjaroen, et al.. (2016). A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 23(10). 2405–2413. 58 indexed citations

Kulkarni, Diptee, Kijoung Song, Linda P. Briley, et al.. (2016). Pyrexia in Dabrafenib-Treated Melanoma Patients is not Associated with Common Genetic Variation or HLA Polymorphisms. Pharmacogenomics. 17(5). 459–462. 7 indexed citations

Kulkarni, Diptee, Judong Shen, Linda P. Briley, et al.. (2014). Pharmacogenetic investigation of dabrafenib efficacy in a meta-analysis of three melanoma studies.. Journal of Clinical Oncology. 32(15_suppl). e20018–e20018. 1 indexed citations

Vázquez, Alexei, Diptee Kulkarni, John E. Kerrigan, et al.. (2010). Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes. Breast Cancer Research and Treatment. 125(3). 861–868. 25 indexed citations

Haffty, Bruce G., Sharad Goyal, Diptee Kulkarni, et al.. (2010). Evaluation of Single Nucleotide Polymorphisms (SNPs) in the p53 Binding Protein 1 (TP53BP1) Gene in Breast Cancer Patients Treated With Breast-Conserving Surgery and Whole-Breast Irradiation (BCS + RT). International Journal of Radiation Oncology*Biology*Physics. 80(2). 385–391. 11 indexed citations

Vázquez, Alexei, Diptee Kulkarni, Lukasz F. Grochola, et al.. (2010). A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence. International Journal of Cancer. 128(10). 2335–2343. 17 indexed citations

Das, Kiron M., Manisha Bajpai, Diptee Kulkarni, et al.. (2010). Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: A novel in vitro model. International Journal of Cancer. 128(2). 274–282. 37 indexed citations

Kulkarni, Diptee, Alexei Vázquez, Bruce G. Haffty, et al.. (2009). A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. Carcinogenesis. 30(11). 1910–1915. 29 indexed citations

10.

Haffty, Bruce G., Sharad Goyal, Devora Schiff, et al.. (2009). Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Breast Cancer Patients Treated with Breast Conserving Surgery and Whole-breast Irradiation (BCS+RT). International Journal of Radiation Oncology*Biology*Physics. 75(3). S6–S6. 1 indexed citations

11.

Park, Hyejin, Haiyan Zheng, Diptee Kulkarni, et al.. (2008). Identification of Phosphorylation Sites of TOPORS and a Role for Serine 98 in the Regulation of Ubiquitin but Not SUMO E3 Ligase Activity. Biochemistry. 47(52). 13887–13896. 9 indexed citations

12.

Gounder, Murugesan, Ahamed Saleem, Pooja Pungaliya, et al.. (2007). Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan. Investigational New Drugs. 26(3). 205–213. 18 indexed citations

13.

Pungaliya, Pooja, Diptee Kulkarni, Hyejin Park, et al.. (2007). TOPORS Functions As A SUMO-1 E3 Ligase for Chromatin-Modifying Proteins. Journal of Proteome Research. 6(10). 3918–3923. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact